Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal?:

作者: Jenna L. Fancher , Robert W. Seabury , William Darko , Luke A. Probst , Christopher D. Miller

DOI: 10.1177/0018578718817471

关键词:

摘要: Purpose: After a sentinel event related to long-acting (LA) opioid administration at our institution and subsequent root cause analysis, an inpatient LA restriction policy was implemented improve patient safety. The objectives of this study were evaluate the effect on therapy utilization compare rates naloxone reversal events among patients administered opioids before after implementation. Methods: To first objective, electronic medical record report created capture all orders prescribed adults between March 1, 2014, July 30, 2017. Utilization compared implementation use controlled for by days. second administrations identified via query Naloxone independently evaluated 2 trained reviewers, third when discrepancies existed. Rates pre- post-policy phase. Results: results objective demonstrate that associated with statistically significant reduction in sustained throughout duration. For 144 deemed have opioid-related event, 12 (18.9%) pre-policy phase 17 (15.9%) This difference not (odds ratio [OR] = 1.629, confidence interval [CI] 0.711-3.732, P .248). Conclusion: A significantly reduced institution. Despite this, we did find reversals opioids. Further is warranted identify optimal method reduce toxicity.

参考文章(9)
Emma C. Davies, Christopher F. Green, Stephen Taylor, Paula R. Williamson, David R. Mottram, Munir Pirmohamed, Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes PLOS ONE. ,vol. 4, ,(2009) , 10.1371/JOURNAL.PONE.0004439
I. A. Dhalla, M. M. Mamdani, M. L.A. Sivilotti, A. Kopp, O. Qureshi, D. N. Juurlink, Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone Canadian Medical Association Journal. ,vol. 181, pp. 891- 896 ,(2009) , 10.1503/CMAJ.090784
Matthew Miller, Catherine W. Barber, Sarah Leatherman, Jennifer Fonda, John A. Hermos, Kelly Cho, David R. Gagnon, Prescription Opioid Duration of Action and the Risk of Unintentional Overdose Among Patients Receiving Opioid Therapy JAMA Internal Medicine. ,vol. 175, pp. 608- 615 ,(2015) , 10.1001/JAMAINTERNMED.2014.8071
David N Juurlink, Irfan A Dhalla, Muhammad M Mamdani, J Michael Paterson, Tara Gomes, Angela Mailis-Gagnon, Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Medicine. ,vol. 5, pp. 13- 22 ,(2011)
Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Kathi Hall, C. Michael Stein, Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain JAMA. ,vol. 315, pp. 2415- 2423 ,(2016) , 10.1001/JAMA.2016.7789
Jan L. Losby, Joel D. Hyatt, Michael H. Kanter, Grant Baldwin, Denis Matsuoka, Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach Journal of Evaluation in Clinical Practice. ,vol. 23, pp. 1173- 1179 ,(2017) , 10.1111/JEP.12756
D.R. Long, A.L. Lihn, S. Friedrich, F.T. Scheffenbichler, K.C. Safavi, S.M. Burns, J.C. Schneider, S.D. Grabitz, T.T. Houle, M. Eikermann, Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England BJA: British Journal of Anaesthesia. ,vol. 120, pp. 1090- 1102 ,(2018) , 10.1016/J.BJA.2017.12.044
Shoshana Herzig, Hilary Mosher, Susan Calcaterra, Anupam Jena, Teryl Nuckols, Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. Journal of Hospital Medicine. ,vol. 13, pp. 263- 271 ,(2018) , 10.12788/JHM.2980